Forte Biosciences Inc (FBRX) Stock Analysis

Forte Biosciences Inc (FBRX) is a publicly traded company in the HEALTHCARE sector. It trades at $18.18, carries a market capitalization of $394.01M. This page summarizes the public market data, fundamentals, and frequently asked questions for FBRX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Forte Biosciences Inc currently has a Neutral sentiment score of 0.04.

About Forte Biosciences Inc

Forte Biosciences Inc. (FBRX), a clinical-stage biopharmaceutical company headquartered in Torrance, California, specializes in the development of innovative therapeutics for skin diseases, particularly eczema and related conditions. Utilizing a proprietary platform grounded in advanced genetic and biological research, Forte aims to deliver targeted treatment solutions that promise enhanced patient outcomes. As the company progresses through clinical trials and regulatory considerations, it i...

GNG Research Analysis

GNG Research scores Forte Biosciences Inc (FBRX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for FBRX.

Frequently Asked Questions

Does FBRX pay dividends?

Forte Biosciences Inc (FBRX) does not currently pay a regular dividend.

What is FBRX's market cap?

Forte Biosciences Inc (FBRX) has a market capitalization of $394.01M with a current stock price of $18.18.